Black Diamond Therapeutics, Inc. (BDTX)
1.325
-0.06
(-4.68%)
USD |
NASDAQ |
Nov 20, 16:00
1.325
0.00 (0.00%)
After-Hours: 19:15
Black Diamond Therapeutics Gross Profit (TTM) : -0.149M for Sept. 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.149M |
| June 30, 2026 | -0.207M |
| March 31, 2026 | -0.265M |
| December 31, 2025 | 69.68M |
| September 30, 2025 | 69.66M |
| June 30, 2025 | 69.66M |
| March 31, 2025 | 69.66M |
| December 31, 2024 | -0.343M |
| September 30, 2024 | -0.344M |
| June 30, 2024 | -1.081M |
| March 31, 2024 | -1.807M |
| December 31, 2023 | -2.533M |
| September 30, 2023 | -3.254M |
| June 30, 2023 | -3.238M |
| March 31, 2023 | -3.239M |
| December 31, 2022 | -3.238M |
| September 30, 2022 | -3.235M |
| Date | Value |
|---|---|
| June 30, 2022 | -3.054M |
| March 31, 2022 | -2.688M |
| December 31, 2021 | -2.217M |
| September 30, 2021 | -1.689M |
| June 30, 2021 | -1.27M |
| March 31, 2021 | -0.836M |
| December 31, 2020 | -0.506M |
| September 30, 2020 | -0.239M |
| June 30, 2020 | -0.045M |
| March 31, 2020 | -0.032M |
| December 31, 2019 | -0.034M |
| September 30, 2019 | -0.037M |
| June 30, 2019 | -0.035M |
| March 31, 2019 | -0.035M |
| December 31, 2018 | -0.023M |
| September 30, 2018 | -0.011M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Lineage Cell Therapeutics, Inc. | 10.00M |
| Armata Pharmaceuticals, Inc. | 5.517M |
| Voyager Therapeutics, Inc. | 21.38M |
| Invivyd, Inc. | 53.96M |
| Elicio Therapeutics, Inc. | -1.142M |